Close
Close
Treatment Database
Sargramostim
Trade Name Leukine
Orphan Indication To reduce neutropenia and leukopenia and decrease the incidence of death due to infection in patients with acute myelogenous leukemia
USA Market Approval 15-09-1995
USA Designation Date 06-03-1995
Sponsor Immunex Corporation
51 University Street
Seattle, Washington, 98101
More about Acute myeloid leukemia
Free Newsletter
Treatment News
Related Videos